TheraRadar
Data updated: Sep 20, 2026

NORISODRINE AEROTROL (isoproterenol hydrochloride) · ABBOTT

Cardiovascular

Details

Status
Discontinued
First Approved
N/A
Routes
INHALATION
Dosage Forms
DISC

Companies

Active Ingredient: ISOPROTERENOL HYDROCHLORIDE

NORISODRINE AEROTROL Approval History

No approval records found
📋

Clinical Trial Registry

1 trials
Trial Sponsor ID Phase Status Title
NCT05997732 STARS Pro00126600 Ph 4 recruiting Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

NORISODRINE AEROTROL FDA Label Details

Track NORISODRINE AEROTROL with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.